cel-sci.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: https://cel-sci.com/wp-sitemap.xml | ||
Meta Tags
| Title | Cel Sci – Cel Sci |
| Description | Dedicated to research and development directed at improving the treatment of cancer, autoimmune and Home About Us Business Strategy Mission and Values History Management Team Board of Directors Technology Multikine What is Multikine Clinical Trial Status |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 206.188.193.103 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
cel-sci.com Valuation
|
US$24,464,006
Last updated: 2022-06-16 23:27:26
cel-sci.com has Semrush global rank of 432,648. cel-sci.com has an estimated worth of US$ 24,464,006, based on its estimated Ads revenue. cel-sci.com receives approximately 2,822,770 unique visitors each day. Its web server is located in United States, with IP address 206.188.193.103. According to SiteAdvisor, cel-sci.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$24,464,006 |
| Daily Ads Revenue | US$22,583 |
| Monthly Ads Revenue | US$677,465 |
| Yearly Ads Revenue | US$8,129,578 |
| Daily Unique Visitors | 188,185 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| cel-sci.com. | A | 86393 | IP: 206.188.193.103 |
| cel-sci.com. | NS | 86400 | NS Record: dns1.stabletransit.com. |
| cel-sci.com. | NS | 86400 | NS Record: dns2.stabletransit.com. |
| cel-sci.com. | MX | 86400 | MX Record: 10 MX1.EMAILSRVR.com. |
| cel-sci.com. | MX | 86400 | MX Record: 20 MX2.EMAILSRVR.com. |
| cel-sci.com. | TXT | 300 | TXT Record: v=SPF1 Include:emailsrvr.com ~All |
HtmlToTextCheckTime:2022-06-16 23:27:26
| Home About Us Business Strategy Mission and Values History Management Team Board of Directors Technology Multikine What is Multikine Clinical Trial Status Phase 3 Trial Design Mechanism of Action Potential Indications Key Publications Leaps What is LEAPS Scientific Backgrounder Key Publications Product Pipeline Investors SEC Filings Stock Chart & Fundamentals Corporate Governance Corporate Presentations News Sign Up For News Careers Contact CEL-SCI Corporation Dedicated to research and development directed at improving the treatment of cancer, autoimmune and infectious diseases. Listen to discussion on the Phase 3 trial results Learn More About Us CEL-SCI is a pioneer in cancer immunotherapy. Our global pivotal Phase III clinical trial in head and neck cancer tested the idea that we should boost the immune system of these patients when it is strongest, after diagnosis, BEFORE the ravages of standard of care therapy (surgery, radiation and chemotherapy). The Phase III trial is the |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: openresty/1.17.8.2 Date: Thu, 21 Oct 2021 22:13:46 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 0 Connection: keep-alive X-Powered-By: PHP/7.0.33 X-Pingback: http://cel-sci.com/xmlrpc.php X-Redirect-By: WordPress Location: https://cel-sci.com/ X-Webcom-Cache-Status: BYPASS HTTP/2 200 server: openresty/1.17.8.2 date: Thu, 21 Oct 2021 22:13:52 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding x-powered-by: PHP/7.0.33 strict-transport-security: max-age=31536000 x-content-type-options: nosniff x-frame-options: SAMEORIGIN x-xss-protection: "1; mode=block" referrer-policy: no-referrer-when-downgrade x-webcom-cache-status: BYPASS |
cel-sci.com Whois Information
Domain Name: CEL-SCI.COM Registry Domain ID: 24616_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2018-11-14T20:32:54Z Creation Date: 1996-04-03T05:00:00Z Registry Expiry Date: 2023-04-04T04:00:00Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.STABLETRANSIT.COM Name Server: DNS2.STABLETRANSIT.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T17:05:59Z <<< |